Equity Overview
Price & Market Data
Price: $10.32
Daily Change: +$0.025 / 0.24%
Daily Range: $10.25 - $10.34
Market Cap: $2,373,775,616
Daily Volume: 1,269
Performance Metrics
1 Week: 2.69%
1 Month: 0.72%
3 Months: 7.28%
6 Months: -16.30%
1 Year: 27.56%
YTD: 1.28%
Company Details
Employees: 1611
Sector: Health technology
Industry: Biotechnology
Country:
Details
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.